title: A closer look at the recommended criteria for disclosing genetic results: perspectives of medical genetic specialists, genomic researchers, and institutional review board chairs.
abstract: Next generation sequencing offers benefit of improved health through knowledge, but comes with challenges, such as inevitable incidental findings (IFs). The applicability of recommended criteria for disclosure of individual results when applied to disclosure of IFs is not well known. The purpose of this study was to examine how medical genetic specialists, genomic researchers, and Institutional Review Board (IRB) chairs perceive the importance of recommended criteria when applied to genetic/genomic IFs. We conducted telephone interviews with medical genetic specialists (genetic counselors, genetic nurses, medical geneticists, laboratory professionals), genomic researchers, and IRB chairs (N = 103). Respondents rated and discussed the importance of nine recommended criteria regarding disclosure of genetic/genomic IFs. Stakeholders agreed the most important criteria for disclosure were: (1) the IF points to a life-threatening condition; (2) there is a treatment; (3) individuals indicate in writing they wanted to be informed of IFs. Criteria rated less important were: analytic validity, high penetrance, association with a young age of onset and relative risk more than 2.0. Respondents indicated that some technical criteria were confusing, and in need of context. Our findings suggest that development of guidelines regarding management of IF include multiple stakeholders' perspectives and be based on a common language.
authors.affiliation: The University of Iowa, Institute for Clinical and Translational Science, Iowa City, IA, USA.
authors.forename: Debra S
authors.initials: DS
authors.lastname: Brandt
authors.forename: Laura
authors.initials: L
authors.lastname: Shinkunas
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Hillis
authors.forename: Sandra E
authors.initials: SE
authors.lastname: Daack-Hirsch
authors.forename: Martha
authors.initials: M
authors.lastname: Driessnack
authors.forename: Nancy R
authors.initials: NR
authors.lastname: Downing
authors.forename: Megan F
authors.initials: MF
authors.lastname: Liu
authors.forename: Lisa L
authors.initials: LL
authors.lastname: Shah
authors.forename: Janet K
authors.initials: JK
authors.lastname: Williams
authors.forename: Christian M
authors.initials: CM
authors.lastname: Simon
mesh_terms: D030881:Disclosure; D005817:Genetic Counseling
references.citation: JAMA. 2001 Nov 14;286(18):2315-21
references.pmid: 11710898
references.citation: Qual Health Res. 2005 Nov;15(9):1277-88
references.pmid: 16204405
references.citation: Am J Med Genet A. 2012 Oct;158A(10):2519-25
references.pmid: 22903777
references.citation: Genet Med. 2012 Apr;14(4):405-10
references.pmid: 22422049
references.citation: J Genet Couns. 2010 Oct;19(5):423-9
references.pmid: 20680423
references.citation: Genet Med. 2012 Apr;14(4):355-7
references.pmid: 22481182
references.citation: Pharmacogenomics J. 2008 Apr;8(2):85-9
references.pmid: 17486108
references.citation: J Law Med Ethics. 2008 Summer;36(2):219-48, 211
references.pmid: 18547191
references.citation: J Empir Res Hum Res Ethics. 2009 Sep;4(3):99-111
references.pmid: 19754239
references.citation: Patient Educ Couns. 2013 Jan;90(1):133-8
references.pmid: 23068909
references.citation: J Empir Res Hum Res Ethics. 2010 Mar;5(1):83-91
references.pmid: 20235866
references.citation: Genet Med. 2012 Apr;14(4):361-84
references.pmid: 22436882
references.citation: JAMA. 2006 Jul 12;296(2):212-5
references.pmid: 16835427
references.citation: Am J Med Genet A. 2006 May 15;140(10):1033-40
references.pmid: 16575896
references.citation: J Law Med Ethics. 2008 Summer;36(2):332-340
references.pmid: 18547202
references.citation: Genet Med. 2011 Jun;13(6):499-504
references.pmid: 21558861
references.citation: Eur J Health Law. 2009 Sep;16(3):229-47
references.pmid: 19788002
references.citation: Circ Cardiovasc Genet. 2010 Dec;3(6):574-80
references.pmid: 21156933
references.citation: Genet Med. 2012 Feb;14(2):215-22
references.pmid: 22241094
references.citation: Sci Transl Med. 2010 Jun 30;2(38):38cm20
references.pmid: 20592417
references.citation: Eur J Hum Genet. 2013 Mar;21(3):248-55
references.pmid: 22739341
references.citation: Genet Med. 2012 Apr;14(4):451-7
references.pmid: 22402755
references.citation: J Empir Res Hum Res Ethics. 2011 Dec;6(4):53-67
references.pmid: 22228060
references.citation: Genet Med. 2012 Feb;14(2):236-42
references.pmid: 22241102
references.citation: J Med Ethics. 2012 Jul;38(7):417-22
references.pmid: 22361295
references.citation: J Genet Couns. 2006 Apr;15(2):77-83
references.pmid: 16761103
references.citation: Nat Rev Genet. 2012 Nov;13(11):818-24
references.pmid: 23076269
references.citation: J Law Med Ethics. 2008 Summer;36(2):292-7, 212
references.pmid: 18547197
references.citation: J Mol Diagn. 2008 Nov;10(6):484-92
references.pmid: 18832462
references.citation: Genet Test Mol Biomarkers. 2012 Jun;16(6):508-13
references.pmid: 22352737
references.citation: Breast Cancer Res. 2009;11 Suppl 3:S12
references.pmid: 20030863
references.citation: J Med Genet. 2009 Jul;46(7):495-6
references.pmid: 19571117
references.citation: J Law Med Ethics. 2008 Summer;36(2):352-5, 213
references.pmid: 18547204